13F

ZBIO ZENAS BIOPHARMA INC

2026Q1 · CUSIP 98937L105 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
138
Δ holders QoQ
+20
Breadth percentile
Top 16%
Whale holders
70
Δ whales
+6
Inst. holding value
$1.1B
New positions
51
Closed positions
31
Price momentum (1Q)
-36.8%
Put / Call
3/3

Breadth history (34 quarters)

2024Q4: Δ+22 · h=66 2025Q1: Δ+1 · h=67 2025Q2: Δ+7 · h=74 2025Q3: Δ+5 · h=79 2025Q4: Δ+39 · h=118 2026Q1: Δ+20 · h=138 2024Q4: holders=66 2025Q1: holders=67 2025Q2: holders=74 2025Q3: holders=79 2025Q4: holders=118 2026Q1: holders=138 -39 -19.5 +0 +19.5 +39 59102145 24Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 16%
2025Q4 Top 14% -36.8%

Options Sentiment

Put holders
3
QoQ: -5
Call holders
3
QoQ: -6

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-9.10
EPS YoY
-275.0%
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2025-03-31: EPS -0.80 2025-06-30: EPS -1.25 2025-09-30: EPS -1.22 2025-12-31: EPS -5.17 2026-03-31: EPS -1.46 -5.69 -2.84 0.00 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)